Hoshino et al. showed that high REV-7 expression in malignant melanomas was associated with increased cancer cell proliferation, and that the inactivation of REV-7 in melanoma cells resulted in increased chemosensitivity to cisplatin but not to dacarbazine [19]. The gene discussed is MAD2L2; the disease is cancer.